Impact of porin deletions on cefepime-taniborbactam activity against <i>Klebsiella pneumoniae</i>
We determined the frequency of resistance to cefepime-taniborbactam in NDM-1-producing <i>Klebsiella pneumoniae</i> at <10<sup>-10</sup>. Isolated mutants that were less susceptible to cefepime-taniborbactam had an increased copy number of the <i>bla</i><sub>NDM-1</sub> gene or disruption of major porins OmpK36 and OmpK35. Antibacterial susceptibility testing using <i>K. pneumoniae</i> isogenic strains indicated that while cefepime penetrates into the periplasm mainly through the major porins, taniborbactam does not have a strong dependence on OmpK35 or OmpK36 for periplasmic accumulation.
Authors
- Tsuyoshi Uehara (ORCID: https://orcid.org/0000-0001-6994-4286)
- Cassandra L. Chatwin
- Denis M. Daigle (ORCID: https://orcid.org/0000-0001-9287-2997)
- John L. Colombo
- Brittany Miller
- Mitchell Edwards
- Annie Stevenson
- Kyoko Uehara
Institutions
- VenatoRx Pharmaceuticals (United States) (US)
Publication Details
- Journal
- Antimicrobial Agents and Chemotherapy
- Published
- 2025-04-02
- DOI
- https://doi.org/10.1128/aac.01672-24
- Citations
- 6
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 3.55
Funders
- Biomedical Advanced Research and Development Authority